Dolphin
Senior Member (Voting Rights)
This contains quite a lot of discussion of ME/CFS, including in the abstract.
Source: OSF Preprints Preprint Date: November 12, 2020 URL: https://osf.io/7gcnv
A Cytokine-based model for the pathophysiology of Long COVID symptoms
---------------------------------------------------------------------
Russell Low(1), Ryan J Low(2), thena Akrami(2)
1. Sharp HealthCare and Sharp Memorial Hospital, 7901 Frost Street San Diego, CA 92123(retired).
2. Sainsbury Wellcome Centre, University College London. 25 Howland St, Fitzrovia, London W1T 4JG, United Kingdom.
* Contact: rnl email: rlow52@yahoo.com
Abstract
The Long COVID group includes patients with mild-to-moderate symptoms, in whom recovery is prolonged, lasting months. Here we propose a model for the pathophysiology of the Long COVID presentation based on inflammatory cytokine cascades and the p38 MAP kinase signaling pathways that regulate cytokine production.
In this model, the SARS-CoV-2 viral infection is hypothesized to trigger a dysregulated peripheral immune system activation with subsequent cytokine release. Chronic low-grade inflammation leads to dysregulated brain microglia with an exaggerated release of central cytokines, producing neuroinflammation. Intermittent fatigue, Post Exertional Malaise (PEM), CNS symptoms with 'brain fog,' arthralgias, paresthesias, and GI and ophthalmic problems can all be attributed to elevated peripheral and central cytokines.
There are abundant similarities between symptoms in Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). A post-infectious ME/CFS model involving a dysfunctional peripheral and central cytokine inflammatory response and autoimmunity is emerging. DNA polymorphisms and viral-induced epigenetic changes to cytokine gene expression may lead to chronic inflammation in Long COVID patients, predisposing some to develop autoimmunity, which may be the gateway to ME/CFS.
Keywords: COVID-19, Cytokines, Long COVID, Long Hauler, Neuroinflammation